Connect with us
[the_ad id="89560"]

Brownstone Institute

Is the WEF the Headquarters of Evil?

Published

17 minute read

This article is printed with permission of the Brownstone Institute
Back in 1983, Ronald Reagan colorfully described the Soviet Union as “the focus of evil in the modern world.” Today, it seems we have a new candidate for the headquarters of all evil: the World Economic Forum headed by Klaus Schwab.

The WEF has no borders, includes all nationalities, embraces governments, NGOs and big business, has no military, nuclear arsenal, flag or anthem, and purports to solve all the world’s problems at its annual conference each year while delegates down champagne and caviar. It sponsors a leadership training program that boasts such covid cultists as Emmanuel Macron, Jacinda Ardern and Justin Trudeau. Is Klaus Schwab the first honest-to-goodness Bond villain, bent on taking over (or depopulating) the world?

Professor Schwab certainly looks the part with his German accent and his prize place on top of the Swiss mountains. He also certainly pretends to run the world. In fact, he has been pretending to run the world since the 1970s, when he started his yearly conferences, hoping to get noticed. Getting noticed took decades. Many of the WEF Young Leaders program graduates presently in power around the world only entered his ‘classes’ 30 years after the WEF started. For decades Klaus has lived the ‘fake it till you make it’ adage. Has he finally made it?

The title of Klaus’ 2020 book “The Great Reset”, coauthored with Thierry Malleret, was catchy enough to be taken on as a slogan during 2020-21 by a slew of political leaders wanting to communicate for myriad local political reasons that the pandemic has opened up some kind of grand reinitialization opportunity in global politics.

Few of these leaders will have read the book though, because if they had, they would have been taken aback by some of its contents. For example: “First and foremost, the post-pandemic era will usher in a period of massive wealth redistribution, from the rich to the poor and from capital to labour.”

Such a view is not commonly spouted by the über-rich barons running global corporations or the governments they influence, for the obvious reason that it constitutes a direct attack on their stash. Certainly they might publicly express the wish for less inequality – who wouldn’t? – but many would baulk at a “massive wealth redistribution,” Robin-Hood style, to labourers and away from capitalists like themselves.

In fact, over the last two years the exact opposite has happened: the world now contains more billionaires and more poor people. “You will own nothing and be happy,” another oft-quoted and much-maligned Schwabism, also describes the opposite of what has actually happened, which can be summarized instead as “the rich own lots more while the poor own nothing and are miserable.”

This year, the WEF meeting in Davos, Switzerland held from May 22-26 triggered the usual outpouring of hatred on Twitter and other platforms. The gossip implies that the WEF is secretly plotting to take over the world by means of a secret collaboration between government and big business, as if rich and powerful people needed a vehicle like the WEF for that. It feels satisfying to those wronged by covid policy to think they have identified the head of the snake responsible for the mess.

The WEF, they claim, is the coordinating platform for all the secret deals that make the rich richer and the entrenched heads of government more powerful, while national and local sovereignty is being clandestinely forfeited, leaving the ordinary person to rot away slowly with neither resources nor rights.

These accusations against the WEF are accompanied by misrepresentation and outright fakery. Photos were recently circulated on social media of hundreds of private planes lined up on an airfield, claimed to be those of attendees at Davos 2022 who were (for shame!) flouting their own pretensions to reduce carbon emissions. According to Reuters, one of the two widely circulated photos was in fact taken years ago at Las Vegas Airport around the time of a boxing title fight between Floyd Mayweather Jr. and Manny Pacquiao, while another was taken in January 2016 at a Swiss air force base that is often used by Davos attendees and was probably associated with the event that year.

None of us was able personally to fly to Davos this year (though some of us have attended such events in the past), but no matter: every session of the 2022 meeting from May 22-26 was posted online.  This included the opening address, via video link, by none other than Ukrainian president Volodymyr Zelensky, resplendent in his trademark brown tee and staring down the camera with unblinking intensity. Invigorated by the President’s defiant address, attendees turned their attention to the remaining 220 or so sessions that covered every weighty and worldly topic under the sun.

We took the time to watch a few, and found them to share a few characteristics.  First, those involved expressed overblown expectations of what would be achieved during the discussions.  Second, the discussions themselves were intelligent and informative. Third, the discussions all led to no particular kind of action.

The basic model of a WEF conference session is to subsidize smart people (the presenters) to say smart things to rich people (the audience), who themselves pay the exorbitant conference registration fees in order to network with each other and have smart people pretend to take them seriously for a few days.

In a word, Klaus Schwab is a glorified and very talented conference planner selling flattery. He pretends that $60,000 provides the attending customer with access to crucial world decisions, all made in 4 days. The hordes paying the entry fee schmooze together, down vast quantities of wine and canapes, and participate in panel discussions that purport to solve problems associated with the world’s economy, environment, and society in end-on-end blocks of 45 minutes each. (Actually, it is closer to 35 minutes, because of 10 minutes of Q&A from the audience squeezed in at the end of each session.  Given the price tag of attendance, the organizers rightly expect some delegates to feel justified in having their moment on the mic.)

Typical of the level of ambition evident in WEF conference sessions, in his introduction to this year’s session on global taxation, host Geoff Cutmore announced that the incipient panel discussion was about getting to a point where “we all feel comfortable about what we’re paying, and we feel comfortable about what other people are paying and we feel comfortable about what corporations are paying and we all feel comfortable about where that tax revenue is ultimately going.”

Whoa.  He might have added, “And if we have a few minutes left over at the end, we’ll work out how to restore the Amazonian rain forest.” The panel consisted of the heads of both Oxfam and the OECD, plus a heavily masked economics professor from Harvard. Imagine what the head of Oxfam would have thought about Cutmore’s pronouncements, given how critical Oxfam has been of the tax evasion and self-enrichment of elites, particularly in the last 2 years.  If only he could get the conference delegates to pay their taxes and stop robbing poor people, he could axe Oxfam altogether!

Some sessions do make the stomach turn. For example, in one, Pfizer announced an “Accord for a Healthier World,”  with its CEO sitting alongside Bill Gates and two African potentates. Announcements like this are made at the WEF, but would they really not exist if not for the WEF? Unlikely. By providing a platform for such announcements, however, it becomes a lightning rod for suspicion. The WEF styles itself an “International Organization for Public-Private Cooperation,” and like any large entity of its kind, it wants to get even bigger and more influential. But at heart, this is business. Klaus Schwab’s business.

The WEF claims serious positive impacts. For example, its ‘First Movers Coalition’ consists of 50 companies that have committed to investing in green technologies and removing carbon. Sounds great, right? The snag, of course, is that they have set up the measurement in such a way that they are able to decide themselves what is meant by ‘green’ or by ‘removing’ carbon. You can count caretaking a forest today as ‘removing’ carbon, and as long as the audience doesn’t know that you cut down and burned a mature forest in the same place last year, they will applaud!

Similarly, the WEF champions a system of reporting called ‘Stakeholder Capitalism Metrics’ (containing environmental, social, and governance, or “ESG,” measures), developed in a cooperative effort with major accounting firms and adopted by 70 companies. Paying a reasonable amount of taxes is not in those KPIs. Nor is free speech. Metrics, but not as you know them.

But what about the smoking gun represented in the many top politicians of today’s world who graduated from the WEF’s Young Leaders program? What about the creepy 2019 WEF conference about what to do in a pandemic?

On the Young Leaders program, it is undoubtedly true that the WEF has become a very successful job networking organization. But it did not invent networking. Networking societies for the rich and powerful have existed for centuries. Think of the Freemasons, the Rotary society, Chatham House, private high schools, Oxbridge, or the Ivy League. The rich and powerful will network with each other, come hell or high water, WEF or no WEF.

Perhaps those who met at the WEF have gelled together on an evil ideology that is bad for the world, but that ideology is clearly not the “Great Reset” ideology articulated by Schwab, since they are not following it in the slightest. Why then does Schwab not protest at how politicians are pretending to enact a Great Reset that is the very opposite of what he advocated in his book? Because he does not really care about his own ideas. A puffed-up conference organizer, Schwab follows his flock of customers rather than leading them. He is being used as a stooge.

OK, but what about that 2019 pandemic simulation conference? Again, you can read all about it online, a level of publicity for their plans that is surely not what you would expect of Bond villains. In these simulations, the WEF folks came to the conclusion that during a pandemic, movement and trade should not be disrupted because of the high costs to society. Yes, you read that right.  Once again, this is the very opposite of what was actually done.

The WEF pandemic conference was just one of the many ‘war games’ simulations that entertain people continuously all around the world. Pandemic simulations this week, asteroid simulations next week, killer bee simulations after that. Rather a lot of problems can be covered off in 220 sessions, and one of them is bound to be tomorrow’s news.

The total disconnect between what his pandemic conference said should be done and what actually happened during covid times is once again proof that Klaus is not led by his principles.  If he were, he would have been loudly protesting what has gone on over the past two years. Instead, he is merely riding his “good luck” that the leaders who came to drink champagne at his events have now embraced him as their supposed figurehead.

Since he is well into his 80s, Klaus probably figures that if an angry world population came to believe that he was responsible for the disaster that has befallen them, he’d be dead long before they came for justice. Thierry Malleret, his younger co-author on “The Great Reset,” has more to worry about in that regard!

The WEF, in sum, is hot air all the way.  It is led by a man who epitomizes pomp, which is nothing new in the circles of the rich and powerful. WEF-approved hot air is no different to the regular variety.

Sure, it’s a place where schmoozing and coordination happen, but the WEF invented neither schmoozing nor the idea of an old-boys club. It is simply the current clubhouse. The real culprits will find another venue the day after the WEF’s shingle is taken down.

Authors

  • Paul Frijters is a Professor of Wellbeing Economics at the London School of Economics: from 2016 through November 2019 at the Center for Economic Performance, thereafter at the Department of Social Policy

  • Gigi Foster, senior scholar of Brownstone Institute, is a Professor with the School of Economics at the University of New South Wales, having joined UNSW in 2009 after six years at the University of South Australia.

  • Michael Baker has a BA (Economics) from the University of Western Australia. He is an independent economic consultant and freelance journalist with a background in policy research.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Brownstone Institute

Net Zero: The Mystery of the Falling Fertility

Published on

From the Brownstone Institute

By Tomas FurstTomas Fürst  

If you want to argue that a mysterious factor X is responsible for the drop in fertility, you will have to explain (1) why the factor affected only the vaccinated, and (2) why it started affecting them at about the time of vaccination.

In January 2022, the number of children born in the Czech Republic suddenly decreased by about 10%. By the end of 2022, it had become clear that this was a signal: All the monthly numbers of newborns were mysteriously low.

In April 2023, I wrote a piece for a Czech investigative platform InFakta and suggested that this unexpected phenomenon might be connected to the aggressive vaccination campaign that had started approximately 9 months before the drop in natality. Denik N – a Czech equivalent of the New York Times – immediately came forward with a “devastating takedown” of my article, labeled me a liar and claimed that the pattern can be explained by demographics: There were fewer women in the population and they were getting older.

To compare fertility across countries (and time), the so-called Total Fertility Rate (TFR) is used. Roughly speaking, it is the average number of children that are born to a woman over her lifetime. TFR is independent of the number of women and of their age structure. Figure 1 below shows the evolution of TFR in several European countries between 2001 and 2023. I selected countries that experienced a similar drop in TFR in 2022 as the Czech Republic.

Figure 1. The evolution of Total Fertility Rate in selected European countries between 2000 and 2023. The data corresponding to a particular year are plotted at the end of the column representing that year.

So, by the end of 2023, the following two points were clear:

  1. The drop in natality in the Czech Republic in 2022 could not be explained by demographic factors. Total fertility rate – which is independent of the number of women and their age structure – dropped sharply in 2022 and has been decreasing ever since. The data for 2024 show that the Czech TFR has decreased further to 1.37.
  1. Many other European countries experienced the same dramatic and unexpected decrease in fertility that started at the beginning of 2022. I have selected some of them for Figure 1 but there are more: The Netherlands, Norway, Slovakia, Slovenia, and Sweden. On the other hand, there are some countries that do not show a sudden drop in TFR, but rather a steady decline over a longer period (e.g. Belgium, France, UK, Greece, or Italy). Notable exceptions are Bulgaria, Spain, and Portugal where fertility has increased (albeit from very low numbers). The Human Fertility Project database has all the numbers.

This data pattern is so amazing and unexpected that even the mainstream media in Europe cannot avoid the problem completely. From time to time, talking heads with many academic titles appear and push one of the politically correct narratives: It’s Putin! (Spoiler alert: The war started in February 2022; however, children not born in 2022 were not conceived in 2021). It’s the inflation caused by Putin! (Sorry, that was even later). It’s the demographics! (Nope, see above, TFR is independent of the demographics).

Thus, the “v” word keeps creeping back into people’s minds and the Web’s Wild West is ripe with speculation. We decided not to speculate but to wrestle some more data from the Czech government. For many months, we were trying to acquire the number of newborns in each month, broken down by age and vaccination status of the mother. The post-socialist health-care system of our country is a double-edged sword: On one hand, the state collects much more data about citizens than an American would believe. On the other hand, we have an equivalent of the FOIA, and we are not afraid to use it. After many months of fruitless correspondence with the authorities, we turned to Jitka Chalankova – a Czech Ron Johnson in skirts – who finally managed to obtain an invaluable data sheet.

To my knowledge, the datasheet (now publicly available with an English translation here) is the only officially released dataset containing a breakdown of newborns by the Covid-19 vaccination status of the mother. We requested much more detailed data, but this is all we got. The data contains the number of births per month between January 2021 and December 2023 given by women (aged 18-39) who were vaccinated, i.e., had received at least one Covid vaccine dose by the date of delivery, and by women who were unvaccinated, i.e., had not received any dose of any Covid vaccine by the date of delivery.

Furthermore, the numbers of births per month by women vaccinated by one or more doses during pregnancy were provided. This enabled us to estimate the number of women who were vaccinated before conception. Then, we used open data on the Czech population structure by age, and open data on Covid vaccination by day, sex, and age.

Combining these three datasets, we were able to estimate the rates of successful conceptions (i.e., conceptions that led to births nine months later) by preconception vaccination status of the mother. Those interested in the technical details of the procedure may read Methods in the newly released paper. It is worth mentioning that the paper had been rejected without review in six high-ranking scientific journals. In Figure 2, we reprint the main finding of our analysis.

Figure 2A. Histogram showing the percentage of women in the Czech Republic aged 18–39 years who were vaccinated with at least one dose of a Covid-19 vaccine by the end of the respective month. Figure 2B. Estimates of the number of successful conceptions (SCs) per 1,000 women aged 18–39 years according to their pre-conception Covid vaccination status. The blue-shaded areas in Figure 1B show the intervals between the lower and upper estimates of the true SC rates for women vaccinated (dark blue) and unvaccinated (light blue) before conception.

Figure 2 reveals several interesting patterns that I list here in order of importance:

  1. Vaccinated women conceived about a third fewer children than would be expected from their share of the population. Unvaccinated women conceived at about the same rate as all women before the pandemic. Thus, a strong association between Covid vaccination status and successful conceptions has been established.
  2. In the second half of 2021, there was a peak in the rate of conceptions of the unvaccinated (and a corresponding trough in the vaccinated). This points to rather intelligent behavior of Czech women, who – contrary to the official advice – probably avoided vaccination if they wanted to get pregnant. This concentrated the pregnancies in the unvaccinated group and produced the peak.
  3. In the first half of 2021, there was significant uncertainty in the estimates of the conception rates. The lower estimate of the conception rate in the vaccinated was produced by assuming that all women vaccinated (by at least one dose) during pregnancy were unvaccinated before conception. This was almost certainly true in the first half of 2021 because the vaccines were not available prior to 2021. The upper estimate was produced by assuming that all women vaccinated (by at least one dose) during pregnancy also received at least one dose before conception. This was probably closer to the truth in the second part of 2021. Thus, we think that the true conception rates for the vaccinated start close to the lower bound in early 2021 and end close to the upper bound in early 2022. Once again, we would like to be much more precise, but we have to work with what we have got.

Now that the association between Covid-19 vaccination and lower rates of conception has been established, the one important question looms: Is this association causal? In other words, did the Covid-19 vaccines really prevent women from getting pregnant?

The guardians of the official narrative brush off our findings and say that the difference is easily explained by confounding: The vaccinated tend to be older, more educated, city-dwelling, more climate change aware…you name it. That all may well be true, but in early 2022, the TFR of the whole population dropped sharply and has been decreasing ever since.

So, something must have happened in the spring of 2021. Had the population of women just spontaneously separated into two groups – rednecks who wanted kids and didn’t want the jab, and city slickers who didn’t want kids and wanted the jab – the fertility rate of the unvaccinated would indeed be much higher than that of the vaccinated. In that respect, such a selection bias could explain the observed pattern. However, had this been true, the total TFR of the whole population would have remained constant.

But this is not what happened. For some reason, the TFR of the whole population jumped down in January 2022 and has been decreasing ever since. And we have just shown that, for some reason, this decrease in fertility affected only the vaccinated. So, if you want to argue that a mysterious factor X is responsible for the drop in fertility, you will have to explain (1) why the factor affected only the vaccinated, and (2) why it started affecting them at about the time of vaccination. That is a tall order. Mr. Occam and I both think that X = the vaccine is the simplest explanation.

What really puzzles me is the continuation of the trend. If the vaccines really prevented conception, shouldn’t the effect have been transient? It’s been more than three years since the mass vaccination event, but fertility rates still keep falling. If this trend continues for another five years, we may as well stop arguing about pensions, defense spending, healthcare reform, and education – because we are done. 

We are in the middle of what may be the biggest fertility crisis in the history of mankind. The reason for the collapse in fertility is not known. The governments of many European countries have the data that would unlock the mystery. Yet, it seems that no one wants to know.


Author

Tomas Furst

Tomas Fürst teaches applied mathematics at Palacky University, Czech Republic. His background is in mathematical modelling and Data Science. He is a co-founder of the Association of Microbiologists, Immunologists, and Statisticians (SMIS) which has been providing the Czech public with data-based and honest information about the coronavirus epidemic. He is also a co-founder of a “samizdat” journal dZurnal which focuses on uncovering scientific misconduct in Czech Science.

Continue Reading

Brownstone Institute

FDA Exposed: Hundreds of Drugs Approved without Proof They Work

Published on

From the Brownstone Institute

By Maryanne Demasi

The US Food and Drug Administration (FDA) has approved hundreds of drugs without proof that they work—and in some cases, despite evidence that they cause harm.

That’s the finding of a blistering two-year investigation by medical journalists Jeanne Lenzer and Shannon Brownleepublished by The Lever.

Reviewing more than 400 drug approvals between 2013 and 2022, the authors found the agency repeatedly ignored its own scientific standards.

One expert put it bluntly—the FDA’s threshold for evidence “can’t go any lower because it’s already in the dirt.”

A System Built on Weak Evidence

The findings were damning—73% of drugs approved by the FDA during the study period failed to meet all four basic criteria for demonstrating “substantial evidence” of effectiveness.

Those four criteria—presence of a control group, replication in two well-conducted trials, blinding of participants and investigators, and the use of clinical endpoints like symptom relief or extended survival—are supposed to be the bedrock of drug evaluation.

Yet only 28% of drugs met all four criteria—40 drugs met none.

These aren’t obscure technicalities—they are the most basic safeguards to protect patients from ineffective or dangerous treatments.

But under political and industry pressure, the FDA has increasingly abandoned them in favour of speed and so-called “regulatory flexibility.”

Since the early 1990s, the agency has relied heavily on expedited pathways that fast-track drugs to market.

In theory, this balances urgency with scientific rigour. In practice, it has flipped the process. Companies can now get drugs approved before proving that they work, with the promise of follow-up trials later.

But, as Lenzer and Brownlee revealed, “Nearly half of the required follow-up studies are never completed—and those that are often fail to show the drugs work, even while they remain on the market.”

“This represents a seismic shift in FDA regulation that has been quietly accomplished with virtually no awareness by doctors or the public,” they added.

More than half the approvals examined relied on preliminary data—not solid evidence that patients lived longer, felt better, or functioned more effectively.

And even when follow-up studies are conducted, many rely on the same flawed surrogate measures rather than hard clinical outcomes.

The result: a regulatory system where the FDA no longer acts as a gatekeeper—but as a passive observer.

Cancer Drugs: High Stakes, Low Standards

Nowhere is this failure more visible than in oncology.

Only 3 out of 123 cancer drugs approved between 2013 and 2022 met all four of the FDA’s basic scientific standards.

Most—81%—were approved based on surrogate endpoints like tumour shrinkage, without any evidence that they improved survival or quality of life.

Take Copiktra, for example—a drug approved in 2018 for blood cancers. The FDA gave it the green light based on improved “progression-free survival,” a measure of how long a tumour stays stable.

But a review of post-marketing data showed that patients taking Copiktra died 11 months earlier than those on a comparator drug.

It took six years after those studies showed the drug reduced patients’ survival for the FDA to warn the public that Copiktra should not be used as a first- or second-line treatment for certain types of leukaemia and lymphoma, citing “an increased risk of treatment-related mortality.”

Elmiron: Ineffective, Dangerous—And Still on the Market

Another striking case is Elmiron, approved in 1996 for interstitial cystitis—a painful bladder condition.

The FDA authorized it based on “close to zero data,” on the condition that the company conduct a follow-up study to determine whether it actually worked.

That study wasn’t completed for 18 years—and when it was, it showed Elmiron was no better than placebo.

In the meantime, hundreds of patients suffered vision loss or blindness. Others were hospitalized with colitis. Some died.

Yet Elmiron is still on the market today. Doctors continue to prescribe it.

“Hundreds of thousands of patients have been exposed to the drug, and the American Urological Association lists it as the only FDA-approved medication for interstitial cystitis,” Lenzer and Brownlee reported.

“Dangling Approvals” and Regulatory Paralysis

The FDA even has a term—”dangling approvals”—for drugs that remain on the market despite failed or missing follow-up trials.

One notorious case is Avastin, approved in 2008 for metastatic breast cancer.

It was fast-tracked, again, based on ‘progression-free survival.’ But after five clinical trials showed no improvement in overall survival—and raised serious safety concerns—the FDA moved to revoke its approval for metastatic breast cancer.

The backlash was intense.

Drug companies and patient advocacy groups launched a campaign to keep Avastin on the market. FDA staff received violent threats. Police were posted outside the agency’s building.

The fallout was so severe that for more than two decades afterwards, the FDA did not initiate another involuntary drug withdrawal in the face of industry opposition.

Billions Wasted, Thousands Harmed

Between 2018 and 2021, US taxpayers—through Medicare and Medicaid—paid $18 billion for drugs approved under the condition that follow-up studies would be conducted. Many never were.

The cost in lives is even higher.

A 2015 study found that 86% of cancer drugs approved between 2008 and 2012 based on surrogate outcomes showed no evidence that they helped patients live longer.

An estimated 128,000 Americans die each year from the effects of properly prescribed medications—excluding opioid overdoses. That’s more than all deaths from illegal drugs combined.

A 2024 analysis by Danish physician Peter Gøtzsche found that adverse effects from prescription medicines now rank among the top three causes of death globally.

Doctors Misled by the Drug Labels

Despite the scale of the problem, most patients—and most doctors—have no idea.

A 2016 survey published in JAMA asked practising physicians a simple question—what does FDA approval actually mean?

Only 6% got it right.

The rest assumed that it meant the drug had shown clear, clinically meaningful benefits—such as helping patients live longer or feel better—and that the data was statistically sound.

But the FDA requires none of that.

Drugs can be approved based on a single small study, a surrogate endpoint, or marginal statistical findings. Labels are often based on limited data, yet many doctors take them at face value.

Harvard researcher Aaron Kesselheim, who led the survey, said the results were “disappointing, but not entirely surprising,” noting that few doctors are taught about how the FDA’s regulatory process actually works.

Instead, physicians often rely on labels, marketing, or assumptions—believing that if the FDA has authorized a drug, it must be both safe and effective.

But as The Lever investigation shows, that is not a safe assumption.

And without that knowledge, even well-meaning physicians may prescribe drugs that do little good—and cause real harm.

Who Is the FDA Working for?

In interviews with more than 100 experts, patients, and former regulators, Lenzer and Brownlee found widespread concern that the FDA has lost its way.

Many pointed to the agency’s dependence on industry money. A BMJ investigation in 2022 found that user fees now fund two-thirds of the FDA’s drug review budget—raising serious questions about independence.

Yale physician and regulatory expert Reshma Ramachandran said the system is in urgent need of reform.

“We need an agency that’s independent from the industry it regulates and that uses high-quality science to assess the safety and efficacy of new drugs,” she told The Lever. “Without that, we might as well go back to the days of snake oil and patent medicines.”

For now, patients remain unwitting participants in a vast, unspoken experiment—taking drugs that may never have been properly tested, trusting a regulator that too often fails to protect them.

And as Lenzer and Brownlee conclude, that trust is increasingly misplaced.

Republished from the author’s Substack

 

Author

Maryanne Demasi, 2023 Brownstone Fellow, is an investigative medical reporter with a PhD in rheumatology, who writes for online media and top tiered medical journals. For over a decade, she produced TV documentaries for the Australian Broadcasting Corporation (ABC) and has worked as a speechwriter and political advisor for the South Australian Science Minister.

Continue Reading

Trending

X